Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimus

IntroductionThe combination of everolimus (EVR) and low-dose tacrolimus (lowTAC) prevents T cell-mediated rejection of liver grafts as sufficiently as high-dose tacrolimus (highTAC) and mycophenolate, but is associated with a preserved kidney function within the first years after orthotopic liver tr...

Descripció completa

Dades bibliogràfiques

Autors principals:	Emily A. Bosselmann, Fabian Dranicki, Alejandro Campos-Murguia, Björn Hartleben, Heiner Wedemeyer, Elmar Jaeckel, Richard Taubert
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-04-01
Col·lecció:	Frontiers in Transplantation
Matèries:	graft injury fibrosis mTOR inhibitor everolimus immunosuppression tacrolimus
Accés en línia:	https://www.frontiersin.org/articles/10.3389/frtra.2023.1168163/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!